Co-Founder & Managing Partner
Nan Li is a co-founder and managing partner of Dimension, a multistage investment firm at the interface of technology and life science. Dimension partners with visionary founders working across therapeutics, diagnostics, software applications, automation systems and tech-enabled services. Nan is interested in the development of cutting-edge technologies including computer vision, AI/ML, NLP, robotics and automation systems.
Over the past decade, Nan has worked with companies developing frontier technologies from early company formation through public markets. This includes Automata, Aspect Biosystems, Recursion Pharma, SwiftScale Biologics (acquired by Resilience), Planet, Iterative Health and Dyno Therapeutics.
Nan holds a BSE in computer science from the University of Michigan. He has also been a lecturer at Stanford University on artificial intelligence and venture capital.